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Objective: Alteration of the antioxidant status in the kidneys may be related to lead (Pb) intoxication.
The present study aimed to investigate the possible beneficial effect of thymoquinone (TQ), the major
active ingredient of the volatile oil of Nigella sativa seeds, on Pb-induced renal antioxidant defense system
impairment.
Methods: A total of thirty two healthy adult male Wistar rats were randomly divided into four equal groups as
follows: a control group, which received no treatment; a Pb group, which was exposed to 2,000 ppm of Pb
acetate in drinking water; a Pb-TQ group, which was cotreated with Pb plus TQ (5 mg/kg/day, per os); and a
TQ group receiving only TQ. All treatments were applied for five weeks.
Results: TQ alone did not induce any significant changes in the antioxidant defense system. By contrast, Pb
exposure significantly decreased reduced glutathione level and superoxide dismutase, glutathione peroxidase,
catalase, and glutathione reductase activities in the renal tissue. Interestingly, supplementation with TQ
significantly improved the affected antioxidant parameters.
Conclusion: Our data are the first to provide evidence on the protective effect of TQ against Pb-induced renal
antioxidant capacity impairment and suggest that this component might be a clinically promising alternative
in Pb nephrotoxicity.
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L
ead (Pb) is a very toxic, non-essential heavy metal.
It is present in storage batteries, water pipes,
plastic, glass, ceramics, paints, insecticides, and
leaded gasoline. Exposure to Pb is impossible to avoid
because it is ubiquitous and persistent in the environ-
ment. Pb poisoning has been reported since the discovery
of Pb thousands of years ago, and it remains a major
health issue worldwide. Air, water, soil, food, and con-
sumer products are the major routes of human exposure
to Pb. The current approved treatment for Pb poisoning
is to administer chelating agents that form an insoluble
complex with the metal and remove it from tissue.
Nevertheless, these chelating agents have no effect
on low levels of exposure and are incapable of removing
metal from intracellular sites; in addition, they cause
many undesirable side effects (1).
After absorption, Pb accumulates primarily in the
kidneys (2), making it a critical target organ for Pb
toxicity. Accumulated Pb in kidneys impairs the endo-
genous antioxidant defense system by inhibiting the main
antioxidant enzymes (superoxide dismutase [SOD], glu-
tathione peroxidase [GPX], catalase [CAT], glutathione
reductase [GR], and glutathione S-transferase [GST]). It
also depletes reduced glutathione (GSH), the most
important intracellular non-enzymatic antioxidant (3).
Medicinal plants nowadays are an important source
of drug synthesis and at least a third of the current drugs
are derived from plants (4). The seeds of Nigella sativa
are known to have healing potential and have been used
for more than 2,000 years as folk medicine in the Middle
East and Far East for a wide range of diseases (5). They
contain more than 30% fixed oil and 0.400.45% (w/w)
volatile oil (6).
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Thymoquinone (TQ) (2-isopropyl-5-methyl-1,4-benzo-
quinone), first extracted by El-Dakhakhny (7), is the
main active and most abundant component (18.424%)
of the essential oil of N. sativa seeds (8). It is structurally
homologous with the coenzyme Q, which is an important
antioxidant in the electron transport chain. The com-
pound can be readily synthesized in gram quantities
by oxidation of thymol with hydrogen peroxide (H2O2)
(9). TQ oral administration is followed by slow absorp-
tion but relatively faster elimination (10). It could lead to
biotransformation due to the metabolizing activity of
liver enzymes such as DT-diaphorase (a quinine reduc-
tase), which catalyzes the reduction of TQ into a
dihydrothymoquinone (11). This metabolite exhibits
antioxidant properties stronger than those of TQ and
similar to those of Trolox, which is considered a standard
antioxidant compound (12). In rats, the LD50 of TQ was
794.3 mg/kg and 57.5 mg/kg for oral and intraperitoneal
administration, respectively (13). TQ has various phar-
macological effects such as antihypertensive (14), antic-
ancer (15), antidiabetic (16), anti-inflammatory (17),
and analgesic properties (18). TQ is also reported to
possess strong antioxidant properties (19). The high
biological activity and low systemic toxicity of TQ make
it a promising alternative to conventional therapeutic
drugs (19).
The influence of TQ on Pb-induced nephrotoxicity has
not previously been studied. Hence, the present study is
the first to investigate the potential protective effect of




Pb acetate trihydrate ([C2H3O2]2Pb. 3H2O) and TQ
(2-isopropyl-5-methyl-1,4-benzoquinone) were purchased
from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA).
All other chemicals used were of the best analytical grade.
Animals
Healthy adult (4-month-old) male Wistar rats, weigh-
ing 200230 g, obtained from the Tunisian Society of
Pharmaceutical Industries, were used in this study. The
animals were housed in plastic cages (free from any
source of chemical contamination) with free access to tap
water (free from Pb) and standard diet. The rats were
kept at 22938C, in a natural light/dark cycle, with 55%
humidity and under a ventilation system. The experi-
ments were started after the animals were allowed to
adapt to the laboratory conditions for a week. All
experimental procedures in this study were in full
compliance with the European Council Directive (86/
609/EEC) and approved by the institutional bioethics
committee.
Experimental design
After the acclimation period, the rats were randomly
divided into four groups of eight animals each and were
treated for five weeks as follows: the control group
received tap water; the Pb group received an aqueous
solution containing 2,000 ppm of Pb acetate (0.2%, w/v)
(2022); the Pb-TQ group was cotreated with Pb (as in
the Pb group) plus TQ (5 mg/kg bw/day); and the TQ
group received tap water and was given TQ (5 mg/kg bw/
day) (2325). TQ was administered by gastric tube daily
between 8:00 and 9:00 am. At the end of the treatment
period, the animals were euthanized by exsanguination
through cardiac puncture under diethyl ether anesthesia.
Tissue collection
The kidneys were removed quickly from the rats, cleared
of adhesive tissue, washed in ice-cold 0.9% (w/v) NaCl
solution, and frozen at 808C until assayed.
Biochemical assays
The kidney tissue was homogenized in 10 volumes of
ice-cold phosphate-buffered saline (136.75 mM NaCl,
2.68 mM KCl, 10.14 mM Na2HPO4, 1.76 mM KH2PO4,
pH 7.4) and the homogenates were centrifuged at
3,500g for 15 min at 48C. The supernatant fractions
were collected and used in biochemical analysis.
SOD (26), GPX (27), and GR (28) activities were de-
termined in the kidney homogenates using commercial
kits (Randox Laboratories Ltd., Crumlin, UK). CAT
activity was determined according to the ferrithiocyanate
method of Cohen et al. (29). The GSH level was deter-
mined spectrophotometrically using the method pre-
viously described by Ellman (30).
Statistical analysis
The results were expressed as mean9SEM. Comparisons
between the groups were performed by Student’s t-test.




As shown in Fig. 1A through D, the kidney activities of
SOD, GPX, CAT, and GR in the rats receiving TQ alone
were not significantly different (p 0.05) from those of
the control group; following Pb treatment, the activities
of these enzymes were significantly decreased (p B0.05)
by 56.11, 58.69, 64.7, and 54.78%, respectively. Interest-
ingly, TQ coadministration significantly attenuated
(p B0.05) the deleterious effect of Pb on the activities
of these antioxidant enzymes. In fact, in the rats cotreated
with Pb and TQ, the renal activities of SOD, GPX, CAT,
and GR significantly increased (pB0.05) by 70.57, 78.85,
106.5, and 73.91%, respectively, in relation to the Pb-
intoxicated rats.
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GSH levels
The results presented in Fig. 2 indicate that the admin-
istration of TQ alone had no significant effect (p0.05)
on kidney GSH level compared to that of the con-
trol group. By contrast, Pb exposure caused a significant
decrease (pB0.05) of about 61.8% in the concentration of
this non-enzymatic antioxidant in relation to the control
rats. This effect was significantly mitigated (pB0.05) by
55.16% when the Pb-treated animals simultaneously
received TQ.
Discussion
Pb is a pervasive environmental and industrial pollutant
with no beneficial biological role, and its toxicity con-
tinues to be a major public health problem throughout
the world. Recent studies point to the potential involve-
ment of the cell’s antioxidant capacity failure in the
pathogenesis of Pb poisoning, suggesting that exogenous
antioxidants may play an effective protective effect. In
the present study, we adopted an in vivo experimental
animal model to investigate whether TQ could maintain
renal intracellular antioxidant reserves in Pb subchronic
treatment.
The metalloproteins SOD, GPX, and CATare the major
antioxidant enzymes. Their activities were used to assess
antioxidant status in cells. SOD catalyzes the dismutation
of superoxide anion radical (O2

) to H2O2 and O2. Because
H2O2 is still harmful to cells, CATand GPX furthercatalyze
the decomposition of H2O2 to water. In the reaction
catalyzed by GPX, GSH is converted into its oxidized
form (GSSG), which can then be reduced back to GSH by
GR. In the present study, we found that treatment with Pb
for five weeks significantly decreased the activities of SOD,
GPX, CAT, and GR in the rat kidney. These results are in
concordance with previous findings (3, 31, 32).
It has been shown that Pb directly alters antioxidant
activities by irreversible direct binding to functional
sulfhydryl (SH) groups of several enzymes such as SOD,


























































































Fig. 1. Effects of lead (Pb), thymoquinone (TQ), and their coadministration on the kidney activities of superoxide dismutase
(SOD, a), glutathione peroxidase (GPX, b), catalase (CAT, c), and glutathione reductase (GR, d) in rats after five weeks. Values
are expressed as mean9SEM of eight animals. Student’s t-test: *pB0.05 versus control; #pB0.05 versus TQ-treated rats;
























Fig. 2. Effects of lead (Pb), thymoquinone (TQ), and their
coadministration on the kidney level of reduced glutathione
(GSH) in rats after five weeks. Values are expressed as
mean9SEM of eight animals. Student’s t-test: *pB0.05
versus control; #pB0.05 versus TQ-treated rats; $pB0.05
versus Pb-treated rats.
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metabolism of essential trace elements such as copper, zinc,
selenium, and iron needed for proper molecular structure
and enzymatic activity (2), the antioxidant enzymes could be
a potential target for Pb toxicity. The decrease in antioxidant
enzyme activities may be explained by the downregulation
of antioxidant enzyme mRNA expression (34).
GSH is a tripeptide-containing cysteine that has a
reactive SH group with reductive potency. Accordingly,
GSH plays a vital role in the protection of cells against
oxidative stress. It can act as a non-enzymatic antioxidant
by direct interaction of SH groups with reactive oxygen
species, or it can be involved in the enzymatic detoxifica-
tion reactions for reactive oxygen species, as a cofactor or
a coenzyme. In agreement with recent investigations
studying the effect of Pb in the kidneys of rats and
mice (35, 36), our data show that Pb treatment signifi-
cantly lowered the renal GSH level.
As for antioxidant enzymes, Pb can damage GSH
directly and/or indirectly. The reduction in concentration
of GSH may be due to the high affinity of Pb to the SH
groups of this tripeptide, thereby interfering with its
antioxidant activity (33). Pb can also decrease the level
of GSH by inhibiting the activities of GSH metabolizing
enzymes, such as GR, GST, and glucose-6-phosphate de-
hydrogenase, by blocking their SH groups (37). Further,
the reduction of GSH synthesis can be proposed as
another explanation.
Despite extensive research now focusing on herbal
products as alternative medicines, no evidence has been
reported in the literature regarding the role of TQ against
Pb-induced renal toxicity. In the present study, cotreat-
ment of Pb-exposed rats with TQ significantly improved
the altered antioxidant defense system in the kidneys.
Our results are in consonance with recent literature
data indicating that oral supplementation of TQ (10 mg/
kg/day, 15 days) protects rat kidneys against sodium
arseniteinduced depletion of antioxidant enzyme activ-
ities (SOD, GPX, and CAT) (38). Furthermore, Farag
et al. (39) reported that TQ (10 mg/kg/day, 28 days)
prevented reduction in kidney SOD activity and GSH
level provoked by chronic treatment with cyclosporine A,
an immunosuppressant drug, and by acute renal ische-
mia/reperfusion in rats. In addition, Samarghandian et al.
(40) reported that TQ enhances the declined renal
antioxidant status in gentamicin-treated rats. TQ (10
mg/kg/day, 10 days, per os) also reversed a renal decrease
in CAT activity and GSH concentration in rats receiving
methotrexate, an anticancer drug (41).
The restoration of tissue antioxidant function by
TQ clearly demonstrated in the current work could be
attributed to its ability to upregulate antioxidant gene
expression (42, 43).
The ability of TQ to correct the disrupted antioxidant
system, as demonstrated in the present research, does not
precisely mean that kidney oxidative stress can be
decreased. Numerous previous data showed that this
component has powerful free radical scavenging activity
(12, 14, 4446), which may be related to the redox pro-
perties of the quinone structure of TQ molecule and to its
unrestricted crossing of morphophysiological barriers to
access subcellular compartments (46). The effect of TQ
on endogenous antioxidants has been relatively poorly
studied. Thus, in the current work we are limited to some
antioxidant markers.
In conclusion, our results clearly indicate that TQ oral
supplementation, at a safe dose, protects against Pb-
induced cellular antioxidant defense system depletion in
rat kidneys. Our findings suggest that TQ may be a
clinically promising agent in Pb nephrotoxicity.
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